You are here

Article info

Article menu
Download PDFPDF
Rare disease
CASE REPORT
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant

Authors

  1. Correspondence to Dr Marie Lind-Holst, marie.lind-holst{at}rsyd.dk
View Full Text

Citation

Lind-Holst M, Hartling UB, Christensen AE
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant
BMJ Case Reports CP 2019;12:e229708.

Publication history

  • Accepted July 1, 2019
  • First published August 4, 2019.
Online issue publication 
January 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.